Chemotherapy, which drugs and when
作者： Miriam Koopman , Cornelis J.A. Punt
DOI: 10.1016/S0959-8049(09)70016-4
关键词:
摘要:
ru.nl
elsevier.com
sci-hub.se 参考文章(57)
Paulo M. Hoff, Rafat Ansari, Gerald Batist, John Cox, Walter Kocha, Mario Kuperminc, Jean Maroun, David Walde, Charles Weaver, Evelyn Harrison, Hans U. Burger, Bruno Osterwalder, Alfred O. Wong, Ralf Wong, Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Study Journal of Clinical Oncology. ,vol. 19, pp. 2282- 2292 ,(2001) , 10.1200/JCO.2001.19.8.2282
Miriam Koopman, Sabine Venderbosch, Harm van Tinteren, Marjolijn J. Ligtenberg, Iris Nagtegaal, Johan H. Van Krieken, Cornelis J. Punt, Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer, a retrospective analysis of the phase III randomised CAIRO study. European Journal of Cancer. ,vol. 45, pp. 1999- 2006 ,(2009) , 10.1016/J.EJCA.2009.04.017
Miriam Koopman, Sabine Venderbosch, Iris D. Nagtegaal, Johan H. van Krieken, Cornelis J. Punt, A review on the use of molecular markers of cytotoxic therapy for colorectal cancer, what have we learned? European Journal of Cancer. ,vol. 45, pp. 1935- 1949 ,(2009) , 10.1016/J.EJCA.2009.04.023
Philippe Rougier, Eric Van Cutsem, Emilio Bajetta, Norbert Niederle, Kurt Possinger, Roberto Labianca, Matilde Navarro, Rudolf Morant, Harry Bleiberg, Jacques Wils, Lucile Awad, Patrice Herait, Christian Jacques, Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer The Lancet. ,vol. 352, pp. 1407- 1412 ,(1998) , 10.1016/S0140-6736(98)03085-2
Hans-Joachim Schmoll, Daniel Sargent, Single agent fluorouracil for first-line treatment of advanced colorectal cancer as standard? The Lancet. ,vol. 370, pp. 105- 107 ,(2007) , 10.1016/S0140-6736(07)61062-9
James Carmichael, Tadeusz Popiela, David Radstone, Stephen Falk, Markus Borner, Amit Oza, Torben Skovsgaard, Stephane Munier, Christophe Martin, Randomized Comparative Study of Tegafur/Uracil and Oral Leucovorin Versus Parenteral Fluorouracil and Leucovorin in Patients With Previously Untreated Metastatic Colorectal Cancer Journal of Clinical Oncology. ,vol. 20, pp. 3617- 3627 ,(2002) , 10.1200/JCO.2002.10.129
M Koopman, G A M Kortman, L Mekenkamp, M J L Ligtenberg, N Hoogerbrugge, N F Antonini, C J A Punt, J H J M van Krieken, Deficient mismatch repair system in patients with sporadic advanced colorectal cancer British Journal of Cancer. ,vol. 100, pp. 266- 273 ,(2009) , 10.1038/SJ.BJC.6604867
S P Ackland, M Jones, D Tu, J Simes, J Yuen, A-M Sargeant, H Dhillon, R M Goldberg, E Abdi, L Shepherd, M J Moore, A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancer British Journal of Cancer. ,vol. 93, pp. 1236- 1243 ,(2005) , 10.1038/SJ.BJC.6602841
Angelo Paradiso, JanMing Xu, Anita Mangia, Annalisa Chiriatti, Gianni Simone, Alfredo Zito, Severino Montemurro, Francesco Giuliani, Evaristo Maiello, Giuseppe Colucci, Topoisomerase‐I, thymidylate synthase primary tumour expression and clinical efficacy of 5‐FU/CPT‐11 chemotherapy in advanced colorectal cancer patients International Journal of Cancer. ,vol. 111, pp. 252- 258 ,(2004) , 10.1002/IJC.20208
R. Adam, E. Avisar, A. Ariche, S. Giachetti, D. Azoulay, D. Castaing, F. Kunstlinger, F. Levi, F. Bismuth, Five-Year Survival Following Hepatic Resection After Neoadjuvant Therapy for Nonresectable Colorectal [Liver] Metastases Annals of Surgical Oncology. ,vol. 8, pp. 347- 353 ,(2001) , 10.1007/S10434-001-0347-3